Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Jan 01, 2012
Design, preparation and characterization of novel molecularly imprinted polymers for removal of potentially genotoxic 1,3-diisopropylurea from API solutions
Read more
Scientific Article
/ Jan 01, 2012
Design of experiments as a tool for LC-MS/MS method development for the trace analysis of the potentially genotoxic 4-dimethylaminopyridine impurity in glucocorticoids
Read more
Scientific Article
Scientific Article